ADCES Diabetes Technology Conference 2025 Resource Hub –
Welcome to our resource hub for ADCES Diabetes Technology 2025! This is a one-stop-shop for all your ADCES Diabetes Technology 2025 needs. ADCES Diabetes Technology Conference 2025 will take place in-person at the Marriott Chicago Downtown Magnificent Mile in Chicago, IL, from December 12-13, 2025. We will be updating the resource hub daily, so check back in for the latest on this fantastic meeting.
Useful Conference Links
- Conference Website
- Conference Registration
- Conference Program
- Day-by-day Conference Preview
- Conference Planning Committee
Day-of Conference Reports
- ADCES Diabetes Technology Conference 2025 Day #1 Highlights
- ADCES Diabetes Technology Conference 2025 Day #2 Highlights
Top Highlights
- Dr. Anders Carlson reviews successes, challenges, and the future of diabetes technologies
- MiniMed 780G product theaters spotlight new Simplera Sync and Instinct CGM options, real-world evidence supporting optimized settings use
- Insights from Omnipod 5 and SECURE-T2D: Expanding access to AID
- Clinical overview of AID systems, including practical approaches with the PANTHER program and CARES framework
- Practical guidance on making CGM implementation work in the real world
- Building efficient diabetes technology workflows across the care team
- Sequel offers a hands-on workshop to demonstrate the differentiating features of the twiist AID system
- Back to school: A step-by-step guide on interpreting AID reports
- Dr. Brynn Marks overviews key barriers preventing AID use in pediatrics: From coverage to algorithms
- Dr. Natalie Bellini and Dr. Diana Isaacs review the role of CGM across the T2D spectrum
- Automated insulin delivery in T2D: An emerging standard of care
- Dr. Anand Iyer positions AI as the “Google Maps” of diabetes care
- Actionable advice for using AID in pregnancy from Dr. Diana Isaacs
- Strategies for remote device training and monitoring: Ms. Teresa McArthur on helping achieve quality care for patients wherever they are
- Drs. Anders Carlson and Kevin Malloy review clinical evidence and case studies for MannKind’s Afrezza (inhaled insulin)
- Clinical considerations on preparing, administering, and monitoring Sanofi’s Tzield (teplizumab) for T1D
- Application of adult learning principles to technology education and training